哮喘与COVID-19:我们终于有答案了吗?
Asthma and COVID-19: do we finally have answers?
PubMed 文献 · Eur Respir J · 2021-03-04
大规模研究证实哮喘患者COVID-19发病率略增,但重症率未增加。由于许多偏倚因素未被纳入,尚无法得出确定性结论。
要点
- 大规模研究显示哮喘患者COVID-19发病率略增,但重症率未增加
- 因偏倚因素未充分考虑,目前尚无确定性结论
- 多数SARS-CoV-2感染为轻症,但重症肺炎比例值得关注
核心结论
- 大规模研究证实哮喘患者COVID-19发病率略增,但重症COVID-19未增加。
- 因许多偏倚因素未被纳入,尚无法得出确定性结论。
主要发现
- 大规模研究显示哮喘患者COVID-19发病率略增。
- 哮喘患者重症COVID-19发生率未见增加。
局限性
- 许多偏倚因素未被纳入分析,无法得出确定性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Large-scale studies confirm previous findings about a slightly increased incidence of COVID-19, but not of severe COVID-19, in asthma patients. Still, no definitive conclusions can be drawn since many bias factors have not been taken into account. https://bit.ly/34FRfmT The coronavirus disease 2019 (COVID-19) pandemic has already claimed the lives of nearly 1.5 million people and the virus is continuing to spread across the world [1]. The disease can affect anyone, and although SARS-CoV-2 infection leads to mild COVID-19 in the majority of cases, the proportion of patients developing severe pneumonia is of great concern.
来源:Eur Respir J,查看原文。版权归原作者所有。
引用
- Eger K, Bel EH. Asthma and COVID-19: do we finally have answers? Eur Respir J. 2021. PMID: 33380511. doi:10.1183/13993003.04451-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。